Medline Inc. (MDLN) stock
Close on Nov 11, 2026Market cap $55.43BP/E –Yield –
Medline Inc. reported revenue of $30.68B for the twelve months to Sep 26, 2026. Free cash flow was $1.90B. At the latest close the market valued the company at $55.43B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 26, 2026
Valuation
- Market cap
- $55.43B
- P/E ratio
- –
- Price to sales
- 1.81
- Price to book
- 4.70
- Dividend yield
- –
- Free cash flow yield
- 3.42%
Fundamentals
- Revenue
- $30.68B
- Net income
- $1.16B
- EPS, diluted
- -$0.01
- Free cash flow
- $1.90B
- Book value per share
- $8.96
- Diluted shares
- 1.32B
Trading
- Next earnings
- Feb 24, 2027 (estimated, before the open)
- Previous close
- $40.91
- Open
- $40.95
- Day's range
- $40.55 – $42.50
- Volume
- 8,314,152
- Average volume (20 days)
- 10,790,054
- Index membership
- Russell 1000 (since Mar 2026), Russell 3000 (since Feb 2026)
- 52-week range
- $31.37 – $50.88
- RSI (14 days)
- 75.2
- Volatility (1 year)
- 47.8%
- Relative volume
- 1.02×
On 2 of our idea lists: Institutions accumulating, Superinvestor favorites
Index membership is inferred from the holdings of funds that track each index (IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | MDLN | S&P 500 | Difference | MDLN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +16.3% | -2.4% | +18.7 pts | ||
| 3 months | +20.3% | -1.2% | +21.5 pts | ||
| Year to date | +0.4% | +12.3% | −11.9 pts |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Medline filed with the SEC as exhibits to Form 8-K or 6-K
About Medline
Surgical & Medical Instruments & Apparatus
Medline Inc. manufactures and distributes medical-surgical supplies and provides healthcare supply chain management services. The company conducts business through two reportable segments: Medline Brand and Supply Chain Solutions. Through its Medline Brand segment, it provides proprietary items spanning patient front-line care, surgical and perioperative environments, and laboratory diagnostics, including wound care supplies, examination gloves, surgical procedure kits, and diagnostic instruments. Through its Supply Chain Solutions segment, Medline distributes third-party medical products alongside logistics optimization, third-party warehousing, consulting, and inventory management services. Its customers encompass all healthcare care settings, including hospitals, ambulatory surgery centers, physician clinics, and post-acute facilities.
Company profile, executives and historyMedline stock: common questions
What is Medline's stock price?
MDLN closed at $42.16 on Nov 11, 2026, up 3.06% on the day. Over the past 52 weeks it traded between $31.37 and $50.88.
What is Medline's market cap?
Medline was worth $55.43B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is MDLN's P/E ratio?
Medline lost money over fiscal 2025 (diluted EPS -$0.01), so it has no meaningful P/E ratio.
How much revenue does Medline make?
Medline reported revenue of $30.68B for the twelve months to Sep 26, 2026.
Does Medline pay a dividend?
No. Medline has not paid a cash dividend over the last twelve months.
When does Medline report earnings next?
Medline is expected to report Q4 FY2026 results on Feb 24, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How many MDLN shares are sold short?
38M shares were sold short at the latest FINRA report, 15.68% of the float, or 3.8 days of average trading volume.
Who are Medline's competitors?
Companies most similar to Medline by business, industry and size include BDX, BSX, SOLV, BAX, SYK.
See a number that looks wrong?